Skip Navigation LinksHome > May 2011 - Volume 90 - Issue 5 > Cognitive Dysfunction Among Cancer Survivors
American Journal of Physical Medicine & Rehabilitation:
doi: 10.1097/PHM.0b013e31820be463
Invited Reviews

Cognitive Dysfunction Among Cancer Survivors

Asher, Arash MD

Collapse Box


Cognitive dysfunction among cancer survivors, commonly referred to as "chemobrain," has gained increased attention in the last decade. Cognitive dysfunction is now well recognized among patients with non-central nervous system cancers. It may be a consequence of the cancer, its treatment, or both. Other common problems among cancer survivors, such as insomnia, pain, depression, and fatigue, may play a role in cognitive performance. Three options to assess cognitive function at present include neuropsychologic testing, functional neuroimaging studies, and subjective evaluations, although no "gold standard" currently exists. Treatment options for survivors with cognitive problems are limited because research in this arena is in its infancy.

© 2011 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.